— Why it moved
Why VIVS Stock Spiked and Collapsed Today — July 15, 2026
A $5M Eli Lilly milestone triggered premarket euphoria to $3.50, the alert caught the very top, and it closed down 74% — the dud of the day.
What moved VIVS stock
VivoSim builds 3D human-tissue models used to test drugs without animals. The catalyst was a $5M milestone payment from Eli Lilly, triggered when the first patient was dosed in a Phase 2 trial for a program Lilly now owns, plus guidance for big revenue growth in 2027. Real money and a marquee partner — but a one-time payment, not a new recurring business.
The mechanics
It's a $2.4M-cap on a 2.3M-share float. Premarket, on thin supply, that combination produced a euphoric spike from under a dollar to $3.50+. There was no depth to hold it there — and when a micro-cap gaps 300% on one-time news, the unwind is usually as violent as the spike.
VIVS by the numbers
The alert window
Stock Pulse flagged VIVS at $3.31 at 8:08 AM, right on the premarket spike. The high, $3.52, printed in that same minute. There was no window — the alert minute was the top. By the regular open the stock had already been cut in half.
How VIVS's move ended
It never recovered. VIVS slid all session and closed at $0.86, down 74% from the alert and roughly back where it started before the news. Real headline, total round-trip — the alert caught the peak of a premarket blow-off. This one was a dud, and we log the losers the same as the winners.
The tell: a milestone payment isn't a re-rating — premarket euphoria on a micro-float round-trips hardest when the number is one-time cash, not recurring revenue.